Links

Tools

Export citation

Search in Google Scholar

Randomized phase II trial of intravenous R05137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168)

Journal article published in 2014 by Chia-Jul Yen, Joong-Won Park, Paul J. Ross, Jean-Marie Peron, Ronnie Tung, Ping Poon, Takuji Okusaka, Baek-Yeol Ryoo, Takayoshi Tanaka, Toshihiko Ohtomo, Olga Rutman, Bruno Daniele, Masatoshi Kudo, Philippe Merle, Oliver Ebert and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload